Serum growth arrest-specific protein (Gas6) levels in SLE patients were higher than in normal controls, and the sensitivity and specificity were 72.7% and 84%, respectively, with a cut-off value of 25.3 ng/mL when discriminating SLE from normal controls (112). This evidence concerns the gene GAS6 and systemic lupus erythematosus.